These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 12970140

  • 1. The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development.
    Bonhomme C, Duluc I, Martin E, Chawengsaksophak K, Chenard MP, Kedinger M, Beck F, Freund JN, Domon-Dell C.
    Gut; 2003 Oct; 52(10):1465-71. PubMed ID: 12970140
    [Abstract] [Full Text] [Related]

  • 2. Regulation of the tumor suppressor homeogene Cdx2 by HNF4α in intestinal cancer.
    Saandi T, Baraille F, Derbal-Wolfrom L, Cattin AL, Benahmed F, Martin E, Cardot P, Duclos B, Ribeiro A, Freund JN, Duluc I.
    Oncogene; 2013 Aug 08; 32(32):3782-8. PubMed ID: 22986531
    [Abstract] [Full Text] [Related]

  • 3. Stimulation of the intestinal Cdx2 homeobox gene by butyrate in colon cancer cells.
    Domon-Dell C, Wang Q, Kim S, Kedinger M, Evers BM, Freund JN.
    Gut; 2002 Apr 08; 50(4):525-9. PubMed ID: 11889074
    [Abstract] [Full Text] [Related]

  • 4. Cdx1, a dispensable homeobox gene for gut development with limited effect in intestinal cancer.
    Bonhomme C, Calon A, Martin E, Robine S, Neuville A, Kedinger M, Domon-Dell C, Duluc I, Freund JN.
    Oncogene; 2008 Jul 24; 27(32):4497-502. PubMed ID: 18372917
    [Abstract] [Full Text] [Related]

  • 5. Phosphorylation of the homeotic tumor suppressor Cdx2 mediates its ubiquitin-dependent proteasome degradation.
    Gross I, Lhermitte B, Domon-Dell C, Duluc I, Martin E, Gaiddon C, Kedinger M, Freund JN.
    Oncogene; 2005 Dec 01; 24(54):7955-63. PubMed ID: 16027724
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The homeobox gene CDX2 in colorectal carcinoma: a genetic analysis.
    Sivagnanasundaram S, Islam I, Talbot I, Drummond F, Walters JR, Edwards YH.
    Br J Cancer; 2001 Jan 01; 84(2):218-25. PubMed ID: 11161380
    [Abstract] [Full Text] [Related]

  • 8. Silencing of CDX2 expression in colon cancer via a dominant repression pathway.
    Hinoi T, Loda M, Fearon ER.
    J Biol Chem; 2003 Nov 07; 278(45):44608-16. PubMed ID: 12947088
    [Abstract] [Full Text] [Related]

  • 9. The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon.
    Mladenova D, Daniel JJ, Dahlstrom JE, Bean E, Gupta R, Pickford R, Currey N, Musgrove EA, Kohonen-Corish MR.
    Gut; 2011 Mar 07; 60(3):350-60. PubMed ID: 20980345
    [Abstract] [Full Text] [Related]

  • 10. Epigenetic silencing of CDX2 is a feature of squamous esophageal cancer.
    Guo M, House MG, Suzuki H, Ye Y, Brock MV, Lu F, Liu Z, Rustgi AK, Herman JG.
    Int J Cancer; 2007 Sep 15; 121(6):1219-26. PubMed ID: 17534889
    [Abstract] [Full Text] [Related]

  • 11. Expression of the Cdx1 and Cdx2 homeotic genes leads to reduced malignancy in colon cancer-derived cells.
    Mallo GV, Soubeyran P, Lissitzky JC, André F, Farnarier C, Marvaldi J, Dagorn JC, Iovanna JL.
    J Biol Chem; 1998 May 29; 273(22):14030-6. PubMed ID: 9593754
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression and localisation of insulin receptor substrate 2 in normal intestine and colorectal tumours. Regulation by intestine-specific transcription factor CDX2.
    Modica S, Morgano A, Salvatore L, Petruzzelli M, Vanier MT, Valanzano R, Esposito DL, Palasciano G, Duluc I, Freund JN, Mariani-Costantini R, Moschetta A.
    Gut; 2009 Sep 29; 58(9):1250-9. PubMed ID: 19221108
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/- compound mutant mice.
    Aoki K, Tamai Y, Horiike S, Oshima M, Taketo MM.
    Nat Genet; 2003 Dec 29; 35(4):323-30. PubMed ID: 14625550
    [Abstract] [Full Text] [Related]

  • 16. Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats.
    Gustafson-Svärd C, Lilja I, Hallböök O, Sjödahl R.
    Gut; 1996 Jan 29; 38(1):79-84. PubMed ID: 8566864
    [Abstract] [Full Text] [Related]

  • 17. CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia.
    Hinoi T, Lucas PC, Kuick R, Hanash S, Cho KR, Fearon ER.
    Gastroenterology; 2002 Nov 29; 123(5):1565-77. PubMed ID: 12404231
    [Abstract] [Full Text] [Related]

  • 18. Absence of acute apoptotic response to genotoxic carcinogens in p53-deficient mice is associated with increased susceptibility to azoxymethane-induced colon tumours.
    Hu Y, Le Leu RK, Young GP.
    Int J Cancer; 2005 Jul 01; 115(4):561-7. PubMed ID: 15700305
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CDX2 downregulation is associated with poor differentiation and MMR deficiency in colon cancer.
    Olsen J, Eiholm S, Kirkeby LT, Espersen ML, Jess P, Gögenür I, Olsen J, Troelsen JT.
    Exp Mol Pathol; 2016 Feb 01; 100(1):59-66. PubMed ID: 26551082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.